DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,436 | -8.6% | 15,050 | +1.2% | 0.00% | – |
| Q2 2023 | $209,370 | -18.5% | 14,870 | -10.5% | 0.00% | -100.0% |
| Q1 2023 | $256,779 | -5.7% | 16,620 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $272,402 | -32.1% | 16,620 | -23.4% | 0.00% | 0.0% |
| Q3 2022 | $401,000 | +40.7% | 21,700 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $285,000 | +41.8% | 21,700 | +0.0% | 0.00% | – |
| Q1 2022 | $201,000 | -5.2% | 21,690 | 0.0% | 0.00% | – |
| Q4 2021 | $212,000 | -71.2% | 21,690 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $737,000 | -6.4% | 21,690 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $787,000 | +8.3% | 21,510 | +32.6% | 0.00% | 0.0% |
| Q1 2021 | $727,000 | -19.1% | 16,219 | +2.9% | 0.00% | -50.0% |
| Q4 2020 | $899,000 | +7.8% | 15,759 | -3.0% | 0.00% | 0.0% |
| Q3 2020 | $834,000 | +2.3% | 16,249 | +19.0% | 0.00% | 0.0% |
| Q2 2020 | $815,000 | +206.4% | 13,649 | +111.0% | 0.00% | +100.0% |
| Q1 2020 | $266,000 | -32.3% | 6,468 | +2.4% | 0.00% | 0.0% |
| Q4 2019 | $393,000 | – | 6,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $11,213,000 | 5.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,580,456 | $51,731,000 | 1.16% |
| ARMISTICE CAPITAL, LLC | 5,836,000 | $54,100,000 | 1.05% |
| Pinz Capital Management, LP | 165,835 | $1,537,000 | 0.96% |
| Sunesis Advisors, LLC | 96,299 | $893,000 | 0.52% |
| Redmile Group, LLC | 664,817 | $6,163,000 | 0.19% |
| PDT Partners, LLC | 222,343 | $2,061,000 | 0.18% |
| Bayesian Capital Management, LP | 41,900 | $388,000 | 0.06% |
| Laurion Capital Management LP | 459,290 | $4,258,000 | 0.05% |
| Hennion & Walsh Asset Management, Inc. | 101,643 | $942,000 | 0.05% |